AARD ▼ -10.4% - Aardvark Therapeutics, Inc. $AARD - Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data 22-OCT-2026 04:05 PM ET